Energy stocks kicked off this year with a bang. As the world economy began to reopen in the wake of COVID-19, demand on oil recovered. This helped crude prices go from the head-scratching negative event on delivery, to over $75 before a sharp downturn late last week. Even with the last week’s 9.56% downside move, the Energy sector is still up 18.49% on the year. But has the easy money already been made here?
Today’s Bear of the Day points out a downside slide in earnings for one energy name,
Select Energy Services
WTTR
.
Select Energy Services, Inc., an oilfield services company, provides water management and chemical solutions to the onshore oil and natural gas industry in the United States. The company operates through three segments: Water Services, Water Infrastructure, and Oilfield Chemicals.
Currently, the stock is a Zacks Rank #5 (Strong Sell), due to negative earnings estimate revisions coming from analysts all over Wall Street. Over the last sixty days, analysts have cut their earnings estimates for the current year and next year. The moves have brought the Zacks Consensus Estimate for FY2021 from a 46-cent loss to a 59-cent loss, before it rounded out at a 54-cent loss. FY2022 has moved from a 20-cent loss to a 21-cent loss then back to a 15-cent loss.
Still, a nice feather in the cap of the bulls here on this one. FY2021 EPS growth is forecast to come in at 86% while FY2022 is 73%. Both years are forecast for a loss but there is meaningful growth there. Revenue growth is there too at 9.3% this year and 17.32% next year.
The Oil and Gas – Field Services industry ranks in the Top 44% of our Zacks Industry Rank. For investors looking to find other names in this industry to research, we have a few which are in the good graces of our Zacks Industry Rank. Those names include Zacks Rank #1 (Strong Buy) stocks
Baker Hughes
BKR
and
Helix Energy Solutions
HLX
.
> n”}” style=”font-weight: bold; font-style: normal; color: rgb(0, 0, 0);”>
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks’ Top Picks to Cash in on Artificial Intelligence
In 2021, this world-changing technology is projected to generate $327.5 billion in revenue. Now Shark Tank star and billionaire investor Mark Cuban says AI will create “the world’s first trillionaires.” Zacks’ urgent special report reveals 3 AI picks investors need to know about today.
See 3 Artificial Intelligence Stocks With Extreme Upside Potential>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report